1. Market Research
  2. > Pharmaceutical Industry

generics Industry, September 2016 Market Reports from Top Publishers

You might be interested in: Pharmaceutical, Therapy, Cloud Computing, Infectious Disease, Neurological Disorder, Blood Disease, Digestive System Disorder, Dermatological Condition, Autoimmune Disease, Cardiovascular Disease, Oil, Leukemia, Genitourinary System Disease, Ophthalmology, Endocrine Disease, Respiratory Disease, Lymphoma, Gas, Cancer, Musculoskeletal Disorder.


 
1-10 of about 200 reports for generics

Purchase Reports From Reputable Market Research Publishers

Orifarm Generics A/S in Consumer Health (Denmark)

Orifarm Generics A/S in Consumer Health (Denmark)

  • $ 143
  • Company report
  • September 2016
  • by Euromonitor International

With its goal of becoming "No 1 in making health care a better deal!", Orifarm Generics will continue to expand its range of generic consumer health products into new categories. In order to fulfil its ...

World Generic Markets 12 SEPTEMBER 2016

World Generic Markets 12 SEPTEMBER 2016

  • $ 1 334
  • Industry report
  • September 2016
  • by Espicom Business Intelligence

Industry Trend Analysis - GDUFA Renegotiation Success Highlights Programme's Importance Industry Brief - Samsung Gains First Health Canada Biosimilar Etanercept Approval Industry Brief - Elite Enters Development ...

Generic Sweden AB

Generic Sweden AB

  • $ 99
  • Company report
  • September 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Generic Sweden AB compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

Generic And Biosimilar Pharmaceuticals Global  Industry Report

Generic And Biosimilar Pharmaceuticals Global Industry Report

  • $ 1 294
  • Industry report
  • September 2016
  • by Plimsoll Publishing Ltd UK

Plimsoll's Generic and Biosimilar Pharmaceuticals (GLOBAL) analysis is the most definitive and accurate study of the Generic and Biosimilar Pharmaceuticals (GLOBAL) sector in 2016. The report is split ...

World Generic Markets 29 AUGUST 2016

World Generic Markets 29 AUGUST 2016

  • $ 1 334
  • Industry report
  • September 2016
  • by Espicom Business Intelligence

Industry Trend Analysis - EpiPen Price Rises Provide Political Fodder Industry Brief - Teligent Gains Health Canada Gentamicin Approval Industry Brief - Teligent Gains Health Canada Baclofen Approval Industry ...

World Generic Markets 15 AUGUST 2016

World Generic Markets 15 AUGUST 2016

  • $ 1 334
  • Industry report
  • August 2016
  • by Espicom Business Intelligence

Industry Trend Analysis - Meda Acquisition Puts Mylan On Track To Become Teva's Main Generics Rival Industry Brief - IntelGenx Sells Bupropion Royalty Industry Trend Analysis - CVS Health Formulary Reflects ...

World Generic Markets 01 AUGUST 2016

World Generic Markets 01 AUGUST 2016

  • $ 1 334
  • Industry report
  • August 2016
  • by Espicom Business Intelligence

Industry Trend Analysis - Path Cleared For Transformational Generic Industry Merger Industry Trend Analysis - Obama Focus Provides Timely Backdrop In Suboxone Litigation Industry Brief - Sandoz' Etanercept ...

Analyzing the Global Generics Industry 2016

Analyzing the Global Generics Industry 2016

  • $ 1 000
  • Industry report
  • August 2016
  • by Aruvian's R'search

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global ...

Fondaparinux Market Analysis by Product (Branded/Generic), and Segment Forecasts to 2024

Fondaparinux Market Analysis by Product (Branded/Generic), and Segment Forecasts to 2024

  • $ 4 700
  • Industry report
  • July 2016
  • by Grand View Research

The global fondaparinux market is expected to reach USD 686.3 million by 2024, according to a new report by Grand View Research, Inc. Fondaparinux is majorly used during knee and hip replacement surgeries. ...

Digital Dose Inhaler Market Analysis By Product (Metered Dose Inhaler, Dry Powder Inhaler), By Type (Branded Medication, Generics Medication) And Segment Forecasts to 2024

Digital Dose Inhaler Market Analysis By Product (Metered Dose Inhaler, Dry Powder Inhaler), By Type (Branded Medication, Generics Medication) And Segment Forecasts to 2024

  • $ 4 700
  • Industry report
  • July 2016
  • by Grand View Research

The global digital dose inhaler market is anticipated to reach a value of USD 3.56 billion by 2024, according to a new report by Grand View Research, Inc. The key factors contributing to the lucrative ...

About 58 000 reports for generics

Download Unlimited Documents from Trusted Public Sources

General Medicine Industry in South Africa

  • August 2014
    177 pages
  • General Medicin...  

    Healthcare  

    Health Insuranc...  

  • South Africa  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.